Phenomic AI is a private platform biotechnology company based in Toronto, Canada. The company specializes in the development of novel antibody-based therapies targeting the tumor stroma and fibrotic diseases. By leveraging advanced artificial intelligence and machine learning tools, the company analyzes complex cell-cell interactions within multi-cell systems to identify new drug targets.